Abstract
Doxycycline (DOXI), a large spectrum antibiotic, when administered in low doses (non-antimicrobial) has an inhibitory effect on extracellular matrix metalloproteinases (MMP), inflammatory mediators and effector molecules associated with myocardial infarction (MI). Studies have shown that DOXI reduces ventricular remodeling and decreases the susceptibility to cardiac arrhythmias after MI. …